 <h1>Alphanate Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>antihemophilic factor / von willebrand factor</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about antihemophilic factor / von willebrand factor. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Alphanate.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to antihemophilic factor / von willebrand factor: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, antihemophilic factor / von willebrand factor may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking antihemophilic factor / von willebrand factor:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty with breathing or swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>hives or welts, itching, rash</li>
<li>nausea</li>
<li>reddening of the skin, especially around the ears</li>
<li>swelling of the face, throat, or tongue</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>blurred vision</li>
<li>cough</li>
<li>headache</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>slow or fast heartbeat</li>
<li>tightness in the chest</li>
<li>vomiting</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to antihemophilic factor / von willebrand factor: intravenous powder for injection</i></p><h3>General</h3><p>The most serious side effects were anaphylaxis/hypersensitivity reactions.<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Allergy, infection, hypersensitivity</p>
<p><b>Uncommon</b> (0.1% to 1%): Factor VIII inhibition</p>
<p><b>Very rare</b> (less than 0.01%): Von Willebrand factor inhibition, anaphylactic shock</p>
<p><b>Frequency not reported</b>: Allergic-anaphylactic reactions, sepsis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (up to 17.5%)</p>
<p><b>Common</b> (1% to 10%): Fever, surgery, facial edema, chest pain, peripheral edema, rigors</p>
<p><b>Frequency not reported</b>: Chills, pseudothrombocytopenia, postoperative pain</p>
<p><b>Postmarketing reports</b>: Fatigue, malaise<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 23.8%), constipation (11.1%)</p>
<p><b>Common</b> (1% to 10%): Gastrointestinal bleeding, abdominal pain, vomiting</p>
<p><b>Frequency not reported</b>: Postoperative nausea<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Groin bleed, ear bleed, shoulder bleed, anemia/hemoglobin decreased, thromboembolic event</p>
<p><b>Frequency not reported</b>: Hemorrhage, hematocrit decreased, postoperative hemorrhage, postoperative wound bleeding</p>
<p><b>Postmarketing reports</b>: Hemolysis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Cerebral hemorrhage/subdural hematoma, dizziness, headache, dysgeusia, somnolence</p>
<p><b>Frequency not reported</b>: Headache, paresthesia, drowsiness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Epistaxis, hemoptysis, pulmonary embolus, sore throat</p>
<p><b>Frequency not reported</b>: Respiratory distress</p>
<p><b>Postmarketing reports</b>: Dyspnea, cough, sneezing, throat irritation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Sweating increased, pruritus, rash, urticaria<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Menorrhagia, hematuria, urinary retention, urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased, liver function test abnormal<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, muscle and joint stiffness</p>
<p><b>Frequency not reported</b>: Extremity pain</p>
<p><b>Postmarketing reports</b>: Joint pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Thrombophlebitis</p>
<p><b>Frequency not reported</b>: Orthostatic hypotension, phlebitis, vasodilation, bradycardia, palpitations<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site erythema or rash or pain</p>
<p><b>Frequency not reported</b>: Injection site bleeding</p>
<p><b>Postmarketing reports</b>: Infusion site pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Pyelonephritis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Postmarketing reports</b>: Hypervolemia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Alphanate (antihemophilic factor-von Willebrand factor)." Alpha Therapeutic Corporation, Los Angeles, CA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Humate-P (antihemophilic factor-von Willebrand factor)." CSL Behring, King of Prussia, PA. </p><p id="ref_5">5. "Product Information. Wilate (antihemophilic factor-von Willebrand factor)." Octapharma USA, Centreville, VA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Alphanate (antihemophilic factor / von willebrand factor)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous coagulation modifiers</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alphanate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Humate-P, Wilate</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hemophilia A</li>
<li>von Willebrand Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to antihemophilic factor / von willebrand factor: intravenous powder for injection</i></p><h3>General</h3><p>The most serious side effects were anaphylaxis/hypersensitivity reactions.<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Allergy, infection, hypersensitivity</p><p><b>Uncommon</b> (0.1% to 1%): Factor VIII inhibition</p><p><b>Very rare</b> (less than 0.01%): Von Willebrand factor inhibition, anaphylactic shock</p><p><b>Frequency not reported</b>: Allergic-anaphylactic reactions, sepsis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (up to 17.5%)</p><p><b>Common</b> (1% to 10%): Fever, surgery, facial edema, chest pain, peripheral edema, rigors</p><p><b>Frequency not reported</b>: Chills, pseudothrombocytopenia, postoperative pain</p><p><b>Postmarketing reports</b>: Fatigue, malaise<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 23.8%), constipation (11.1%)</p><p><b>Common</b> (1% to 10%): Gastrointestinal bleeding, abdominal pain, vomiting</p><p><b>Frequency not reported</b>: Postoperative nausea<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Groin bleed, ear bleed, shoulder bleed, anemia/hemoglobin decreased, thromboembolic event</p><p><b>Frequency not reported</b>: Hemorrhage, hematocrit decreased, postoperative hemorrhage, postoperative wound bleeding</p><p><b>Postmarketing reports</b>: Hemolysis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Cerebral hemorrhage/subdural hematoma, dizziness, headache, dysgeusia, somnolence</p><p><b>Frequency not reported</b>: Headache, paresthesia, drowsiness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Epistaxis, hemoptysis, pulmonary embolus, sore throat</p><p><b>Frequency not reported</b>: Respiratory distress</p><p><b>Postmarketing reports</b>: Dyspnea, cough, sneezing, throat irritation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Sweating increased, pruritus, rash, urticaria<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Menorrhagia, hematuria, urinary retention, urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased, liver function test abnormal<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, muscle and joint stiffness</p><p><b>Frequency not reported</b>: Extremity pain</p><p><b>Postmarketing reports</b>: Joint pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Thrombophlebitis</p><p><b>Frequency not reported</b>: Orthostatic hypotension, phlebitis, vasodilation, bradycardia, palpitations<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site erythema or rash or pain</p><p><b>Frequency not reported</b>: Injection site bleeding</p><p><b>Postmarketing reports</b>: Infusion site pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Blurred vision<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Pyelonephritis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Postmarketing reports</b>: Hypervolemia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Alphanate (antihemophilic factor-von Willebrand factor)." Alpha Therapeutic Corporation, Los Angeles, CA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. "Product Information. Humate-P (antihemophilic factor-von Willebrand factor)." CSL Behring, King of Prussia, PA. </p><p id="ref_5">5. "Product Information. Wilate (antihemophilic factor-von Willebrand factor)." Octapharma USA, Centreville, VA. </p><h2>More about Alphanate (antihemophilic factor / von willebrand factor)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous coagulation modifiers</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Alphanate &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hemophilia A</li>
<li>von Willebrand Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>